Document is current
Any future updates will be listed below
-
Authors
Gadeberg, Trine Amalie Fogh
Jørgensen, Martin Høgholm https://orcid.org/0000-0002-4459-5523
Olesen, Heidi Gytz
Lorentzen, Josefine https://orcid.org/0000-0003-0219-2168
Harwood, Seandean Lykke
Almeida, Ana Viana
Fruergaard, Marlene Uglebjerg
Jensen, Rasmus Kjeldsen https://orcid.org/0000-0001-5472-4862
Kanis, Philipp https://orcid.org/0000-0003-4705-4447
Pedersen, Henrik
Tranchant, Emil https://orcid.org/0000-0002-4755-1796
Petersen, Steen Vang
Thøgersen, Ida Buch
Kragelund, Birthe Brandt https://orcid.org/0000-0002-7454-1761
Lyons, Joseph Anthony https://orcid.org/0000-0003-0218-4862
Enghild, Jan Johannes https://orcid.org/0000-0001-9292-9172
Andersen, Gregers Rom https://orcid.org/0000-0001-6292-3319
- License Information
-
More Information
Article History
Received: 16 June 2023
Accepted: 3 December 2024
First Online: 23 January 2025
Competing interests
: G.R.A., H.P. and R.K.J. are inventors on patents describing the hC3Nb2 nanobody and the EWEµH fusion protein. H.G.O. is co-founder of Commit Biologics, which has licensed these patents. The remaining authors declare no competing interests.
